Verastem (VSTM) Tops Q2 EPS by 6c

Verastem (NASDAQ: VSTM) reported Q2 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).

Financial Guidance

Based on current operating plans, we expect to have sufficient cash, cash equivalents and short-term investments to fund our research and development programs and operations into 2018.

For earnings history and earnings-related data on Verastem (VSTM) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BMO Capital Upgrades CES Energy Solutions Corp. (CEU:CN) (CESDF) to Outperform
• BTIG Reiterates Buy Rating on Verastem (VSTM)